ArticleMethylene Blue and Cancer: What the Laboratory Research Shows
Methylene blue is approved for one blood condition and studied in cancer cells and mice. No human trial shows it treats cancer, and it interacts with common medicines.
8 matches across articles, videos and resources.
ArticleMethylene blue is approved for one blood condition and studied in cancer cells and mice. No human trial shows it treats cancer, and it interacts with common medicines.
ArticleMebendazole, a long-used deworming drug, shows anticancer activity in lab models. Human data are limited and early, and liver and marrow effects matter.
ArticleIvermectin has shown effects on cancer cells in the lab, but at levels far above what people can reach. Human evidence is very limited, and safety matters.
Video: lab and mouse research on the peptide BPC-157 in melanoma cells and cancer cachexia. Preclinical only, with no human cancer trials.
ArticleDr. Johnston ranks the ten supplements and repurposed generic drugs he would put on his own shortlist, weighing human trials first, then animal and laboratory research.
Video: a randomized, placebo-controlled trial found fewer recurrent colorectal adenomas with berberine after polyp removal. Prevention research, not treatment.
Video: a 2016 lab and mouse study of dandelion root extract in colon cancer cells. Preclinical only, with no adequate human cancer trials yet.
Video: a 40-patient randomized trial added mebendazole to chemotherapy for metastatic colorectal cancer. Small study, larger trials needed. Not medical advice.